These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 6970636

  • 21. Leishmania mexicana and Leishmania tropica major: adoptive transfer of immunity in mice.
    Alexander J, Phillips RS.
    Exp Parasitol; 1980 Feb; 49(1):34-40. PubMed ID: 6965278
    [No Abstract] [Full Text] [Related]

  • 22. L3T4+ T cells promoting susceptibility to murine cutaneous leishmaniasis express the surface marker Ly-24 (Pgp-1).
    Moll H, Scollay R.
    Eur J Immunol; 1989 Feb; 19(2):307-14. PubMed ID: 2467816
    [Abstract] [Full Text] [Related]

  • 23. Functional heterogeneity of CD4+ T cells in leishmaniasis.
    Liew FY.
    Immunol Today; 1989 Feb; 10(2):40-5. PubMed ID: 2568842
    [Abstract] [Full Text] [Related]

  • 24. [Clinical immunological variants of leishmaniasis].
    Shuĭkina EE.
    Med Parazitol (Mosk); 1980 Feb; 49(3):75-81. PubMed ID: 6993910
    [No Abstract] [Full Text] [Related]

  • 25. Macrophage heterogeneity and Ir-gene control as factors involved in the immune response of guinea pigs to infection with Leishmania enrietti.
    Gorczynski RM, MacRae S, Kuba R, Price GB.
    Cell Immunol; 1981 May 15; 60(2):367-75. PubMed ID: 6786761
    [No Abstract] [Full Text] [Related]

  • 26. [Parasitic evasion mechanisms: Leishmania as an example].
    Solbach W, Bogdan C, Moll H, Lohoff M, Röllinghoff M.
    Immun Infekt; 1989 Aug 15; 17(4):129-40. PubMed ID: 2673994
    [Abstract] [Full Text] [Related]

  • 27. [Phagedena due to leishmaniasis. Immunologic and experimental studies].
    Akhound-Zadeh H.
    Ann Dermatol Syphiligr (Paris); 1976 Aug 15; 103(1):23-30. PubMed ID: 793505
    [Abstract] [Full Text] [Related]

  • 28. The role of the macrophage in cutaneous leishmaniasis.
    Farah FS, Samra SA, Nuwayri-Salti N.
    Immunology; 1975 Oct 15; 29(4):755-64. PubMed ID: 1184120
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Immunological responses of L. donovani infection in mice and significance of T cell in resistance to experimental leishmaniasis.
    Rezai HR, Farrell J, Soulsby EL.
    Clin Exp Immunol; 1980 Jun 15; 40(3):508-14. PubMed ID: 6968259
    [Abstract] [Full Text] [Related]

  • 35. Cell contact-mediated macrophage activation for antileishmanial defense. II. Identification of effector cell phenotype and genetic restriction.
    Sypek JP, Panosian CB, Wyler DJ.
    J Immunol; 1984 Dec 15; 133(6):3351-7. PubMed ID: 6333458
    [Abstract] [Full Text] [Related]

  • 36. Adoptive transfer of anti-syphilis immunity with lymphocytes from Treponema pallidum-infected guinea pigs.
    Pavia CS, Niederbuhl CJ.
    J Immunol; 1985 Oct 15; 135(4):2829-34. PubMed ID: 3897379
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Cellular immunity to Leishmania donovani. I. The effect of T cell depletion on resistance to L. donovani in mice.
    Skov CB, Twohy DW.
    J Immunol; 1974 Dec 15; 113(6):2004-11. PubMed ID: 4214869
    [No Abstract] [Full Text] [Related]

  • 39. Macrophage activation by interferon-gamma from host-protective T cells is inhibited by interleukin (IL)3 and IL4 produced by disease-promoting T cells in leishmaniasis.
    Liew FY, Millott S, Li Y, Lelchuk R, Chan WL, Ziltener H.
    Eur J Immunol; 1989 Jul 15; 19(7):1227-32. PubMed ID: 2503386
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.